Navigation Links
myMatrixx's Phil Walls, R.Ph. Receives National and Regional Recognition
Date:10/5/2011

TAMPA, Fla., Oct. 5, 2011 /PRNewswire/ -- myMatrixx®, a full-service pharmacy and ancillary medical benefits management company for worker's compensation, announced today that Phil Walls, R.Ph., Chief Clinical & Compliance Officer, has been named a finalist in two prestigious awards programs. The first is Health Care Heroes hosted by the Tampa Bay Business Journal in which Phil is a finalist in the Medical Professional Non-Physician category. Phil will be recognized with other honorees at an awards ceremony on October 13 for making a significant impact in the region's health care community.

(Logo: http://photos.prnewswire.com/prnh/20111005/FL81065LOGO)

Phil has also been named a finalist in The Dorland Health People Awards, a national program recognizing healthcare professionals in the Pharmacist category. The Dorland awards honors individuals who are making a difference in transitioning the patient through the complicated healthcare landscape. Phil will be honored at an awards ceremony in Washington, D.C., on October 20 where the award winners will be announced.

"All of us at myMatrixx are extremely proud of Phil and the recognition he has received both regionally and nationally," stated Steven MacDonald, CEO of myMatrixx. "His contribution to the clinical programs we provide our clients has been crucial to our success and I cannot think of anyone more deserving of these honors," added MacDonald.

Joseph Paduda of Health Strategy Associates agrees, "Phil is very knowledgeable about the complex issues inherent in managing drug therapy in workers' comp. Phil's ability to combine that knowledge with practical experience and compassion for the injured worker is apparent to anyone who has worked closely with him," added Paduda.

For more information on the Health Care Heroes Awards visit the Tampa Bay Business Journal website and for the Dorland Heath People Awards visit the Dorland Health website.

About myMatrixx myMatrixx is a full-service pharmacy and ancillary medical benefits management company focusing on the "Customer Experience." The company's Technology Plus™ platform and approach combines advanced technology, expert clinical support, productivity-improving processes, real-time alerts and comprehensive reporting to simplify the management of worker's compensation claims. The result is a reduction of costs and improved outcomes for clients and their injured workers. Contact:Lori Taylor, Director of Marketing and Communications(877) 804-4900, ext 136 or ltaylor@mymatrixx.com
'/>"/>

SOURCE myMatrixx
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Neurocrine Biosciences Receives Second Milestone Payment of $20 Million Under Abbott Collaboration Agreement
2. Bioness Inc. Receives FDA Clearance and CE Mark for Its NESS H200 Wireless System for Hand Paralysis as a Result of Stroke and Other Central Nervous System Disorders
3. Siemens Mobilett Mira Mobile Digital X-Ray System Receives FDA Clearance
4. Cardiac Dimensions® Receives CE Mark Approval for Enhanced CARILLON® Mitral Contour System™
5. Awarepoint Corporation Receives Frost & Sullivans 2011 North American RFID and RTLS Healthcare Competitive Strategy Leadership Award
6. Synapse Biomedical Receives FDA Approval for NeuRx Diaphragm Pacing System (DPS)® to Treat Amyotrophic Lateral Sclerosis (ALS)
7. Medical Alarm Concepts Receives Growth Capital Injection and Commitment for Future Funding
8. Kimberly-Clark Health Care Receives Landmark FDA Clearance for Pediatric Face Mask
9. Ampio Pharmaceuticals Receives Notice of Allowance of its Two Patent Applications on the Combination of Zertane™ with Erectile Dysfunction Drugs in Canada
10. American Oriental Bioengineering Inc. Receives NYSE Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
11. ULURU Inc. Receives NYSE Amex Notice of Non-Compliance with Continued Listing Standards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... -- Accuray Incorporated (Nasdaq: ARAY ) announced ... set the bar for excellence in customer satisfaction. The ... rating among radiation treatment delivery systems in the U.S., ... Briefing™. The most recent ratings trend also shows Accuray ... for 11 of the past 12 quarters. ...
(Date:1/19/2017)... 19, 2017 Shire plc (LSE: ... U.S. Food and Drug Administration (FDA) has acknowledged receipt ... Application (NDA) for SHP465, a long-acting, triple-bead, mixed amphetamine ... once-daily treatment for Attention-Deficit/Hyperactivity Disorder (ADHD). The FDA is ... 20, 2017, the designated Prescription Drug User Fee Act ...
(Date:1/19/2017)... The global  pacemaker market  is expected to reach USD ... Inc. The heightening prevalence of cardiac conditions coupled with the availability of medical ... addition, technological enhancements in these devices are supporting the expansion of this vertical. ... ... Grand View Research Logo ...
Breaking Medicine Technology:
(Date:1/19/2017)... ... January 19, 2017 , ... Dr. ... Board of Dermatology and fellowship trained Mohs and cosmetic surgeon. After extensive dermatology ... Dr. Li completed his internship in internal medicine at the Emory University and ...
(Date:1/19/2017)... , ... January 19, 2017 , ... ... now offering treatments for patients with sleep apnea and TMJ disorders. These conditions ... and physical health. Dr. Rassouli provides personalized care to reduce the risk of ...
(Date:1/19/2017)... ... January 19, 2017 , ... Rountree ... planning services to communities throughout eastern Georgia, is embarking on a charity effort ... Heart disease kills more Americans every year than anything else, yet risk factors ...
(Date:1/19/2017)... ... January 19, 2017 , ... Creative messages ... Real Impact contest from Impact Teen Drivers and California Casualty. Entries from students ... , Educational grants totaling $15,000 will be awarded for the best peer-to-peer messages ...
(Date:1/19/2017)... ... , ... The 21st Century Cures Act’s Impact on Medical Devices:, What You ... 1:30 p.m. – 3:00 p.m. ET, http://www.fdanews.com/21stcenturycures          , What do ... this year? , The passage of the act means devicemakers will be scrambling to ...
Breaking Medicine News(10 mins):